These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35576811)

  • 1. Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing.
    Gulimiheranmu M; Li S; Zhou J
    Stem Cell Res; 2022 Jul; 62():102805. PubMed ID: 35576811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Maierhof SK; Schinke C; Cernoch J; Hew L; Bruske LP; Fernandez Vallone V; Fischer K; Stachelscheid H; Huehnchen P; Endres M; Diecke S; Telugu NS; Boehmerle W
    Stem Cell Res; 2023 Dec; 73():103253. PubMed ID: 37984032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
    Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
    Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
    Getachew H; Chinchilla B; Fernandez-Godino R
    Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing.
    Diouf D; Vitale MR; Zöller JEM; Pineau AM; Klopocki E; Hamann C; Ziegler GC; Vanmierlo T; Van den Hove D; Lesch KP
    Stem Cell Res; 2023 Mar; 67():103038. PubMed ID: 36746102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
    Ben Jehuda R; Shemer Y; Binah O
    Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a homozygous (MCRIi031-A-3) WT1 knockout human iPSC line.
    Pachernegg S; Robevska G; Ferreira LGA; van den Bergen JA; Vlahos K; Howden SE; Sinclair AH; Ayers KL
    Stem Cell Res; 2024 Sep; 79():103494. PubMed ID: 39003885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a homozygous ABCA7-knockout human iPSC line using the CRISPR/Cas9 system.
    Guan M; Chai Y; Yi R; Chen Y; Ip JPK; Ye T; Chen Y
    Stem Cell Res; 2023 Feb; 66():103000. PubMed ID: 36521383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a
    Nouri P; Zimmer A; Brüggemann S; Friedrich R; Kühn R; Prakash N
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing.
    Adkar SS; Wu CL; Willard VP; Dicks A; Ettyreddy A; Steward N; Bhutani N; Gersbach CA; Guilak F
    Stem Cells; 2019 Jan; 37(1):65-76. PubMed ID: 30378731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an NANS homozygous knockout human induced pluripotent stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9 editing.
    Bu Q; Zhang H; Liu Q; Dai Y; Wei Q; Xue A; Huang Y; Zhong K; Huang Y; Gao H; Cen X
    Stem Cell Res; 2020 Dec; 49():102052. PubMed ID: 33130469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of RUNX1c-eGFP induced pluripotent stem cell, MUSIi012-A-4, using CRISPR/Cas9.
    Srisook P; Laowtammathron C; Lorthongpanich C; Klaihmon P; Terbto P; Waeteekul S; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2023 Mar; 67():103035. PubMed ID: 36753833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of heterozygous (MCRIi031-A-1) and homozygous (MCRIi031-A-2) SOX9 knockout human iPSC lines.
    Pachernegg S; Robevska G; G A Ferreira L; van den Bergen JA; Vlahos K; Howden SE; Sinclair AH; Ayers KL
    Stem Cell Res; 2024 Sep; 79():103484. PubMed ID: 38924973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing.
    Chen D; Song B; Cheng Y; Zhu L; Lu D; Liu N; Yang Y; Sun X
    Stem Cell Res; 2021 Aug; 55():102494. PubMed ID: 34403853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a GLA knock-out human-induced pluripotent stem cell line, KSBCi002-A-1, using CRISPR/Cas9.
    Kim YK; Yu JH; Min SH; Park SW
    Stem Cell Res; 2020 Jan; 42():101676. PubMed ID: 31841972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.